Nako Nakatsuka: I mean, the “Talented 12 Symposium” was just so amazing. I loved hearing about Frances Arnold’s story. It’s ...

He says he sees an opportunity for TCEs to act as simpler and more scalable alternatives to cell-based therapies for ...

The legislation is intended to prevent US pharmaceutical companies that receive federal funding from working with five ...

The European battery leader Northvolt is scaling back plans to manufacture battery chemicals and will focus instead on ...

Proteolipid vehicles merge directly with the cell membrane, skipping a pathway that traps many DNA and RNA therapies.